Trevi Therapeutics, Inc. Preferred Stock, Dividend Rate, Percentage
Trevi Therapeutics, Inc. (TRVI) reported Preferred Stock, Dividend Rate, Percentage of 6.00% for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Notes › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2021-03-25
- Trevi Therapeutics, Inc. preferred stock, dividend rate, percentage for fiscal 2019 was 6.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 0 month | Preferred Stock, Dividend Rate, Percentage 1 month | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | 6.00% 10-K · filed 2020-03-16 | ||||
| 2019-09-30 | 6.00% 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | 6.00% 10-Q · filed 2019-08-12 | ||||
| 2019-05-09 | 6.00% 10-K · filed 2021-03-25 | ||||
| 2019-03-31 | 6.00% 10-Q · filed 2019-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |